Skip to main content

Table 8 Comparison according to tumor recurrence among HCC group regarding amphiregulin and AFP levels

From: Amphiregulin as a novel diagnostic and prognostic biomarker of hepatocellular carcinoma before and after locoregional treatment

Time

Recurrence (N = 5)

Remission (N = 25)

^P value

AFP (ng/mL)

 Baseline

565.0 ± 207.7

757.5 ± 733.0

0.278

 Follow-up

1343.4 ± 907.3

592.0 ± 643.3

0.034*

Amphiregulin (pg/mL)

 Baseline

24.5 ± 12.4

23.0 ± 11.6

0.798

 Follow-up

30.8 ± 14.1

17.2 ± 8.8

0.008*

  1. ^Independent t test
  2. *Significant